These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9748672)

  • 1. Detecting new lesion formation in multiple sclerosis: the relative contributions of monthly dual-echo and T1-weighted scans after triple-dose gadolinium.
    Filippi M; Mastronardo G; Rocca MA; Capra R; Gasperini C; Rovaris M; Bastianello S; Comi G
    Eur Neurol; 1998 Oct; 40(3):146-50. PubMed ID: 9748672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.
    Rovaris M; Mastronardo G; Prandini F; Bastianello S; Comi G; Filippi M
    J Neurol Sci; 1999 Apr; 164(2):148-52. PubMed ID: 10402026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging.
    Tortorella C; Codella M; Rocca MA; Gasperini C; Capra R; Bastianello S; Filippi M
    J Neurol; 1999 Aug; 246(8):689-92. PubMed ID: 10460446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images.
    Rovaris M; Barkhof F; Bastianello S; Gasperini C; Tubridy N; Yousry TA; Sormani MP; Viti B; Miller DH; Filippi M
    J Neurol; 1999 Oct; 246(10):920-5. PubMed ID: 10552239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions.
    Filippi M; Rovaris M; Bastianello S; Gasperini C; Origgi D; Reganati P; Pozzilli C; Comi G
    J Neurol; 1999 Feb; 246(2):97-106. PubMed ID: 10195404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium.
    Filippi M; Rocca MA; Rizzo G; Horsfield MA; Rovaris M; Minicucci L; Colombo B; Comi G
    Neurology; 1998 May; 50(5):1289-93. PubMed ID: 9595976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis.
    Filippi M; Mastronardo G; Bastianello S; Rocca MA; Rovaris M; Gasperini C; Pozzilli C; Comi G
    J Neurol Sci; 1998 Jul; 159(1):94-101. PubMed ID: 9700710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
    Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis.
    Filippi M; Rocca MA; Martino G; Horsfield MA; Comi G
    Ann Neurol; 1998 Jun; 43(6):809-14. PubMed ID: 9629851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging.
    Filippi M; Rocca MA; Sormani MP; Pereira C; Comi G
    Magn Reson Imaging; 1999 Sep; 17(7):979-84. PubMed ID: 10463647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging.
    Filippi M; Iannucci G; Cercignani M; Assunta Rocca M; Pratesi A; Comi G
    Arch Neurol; 2000 Jul; 57(7):1017-21. PubMed ID: 10891984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis.
    Filippi M; Yousry T; Rocca MA; Fesl G; Voltz R; Comi G
    Acta Neurol Scand; 1997 Jun; 95(6):331-4. PubMed ID: 9228265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement.
    Filippi M; Rocca MA; Comi G
    J Neurol Sci; 1998 Aug; 159(2):162-5. PubMed ID: 9741401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI evolution of new MS lesions enhancing after different doses of gadolinium.
    Rovaris M; Mastronardo G; Gasperini C; Prandini F; Yousry TA; Filippi M
    Acta Neurol Scand; 1998 Aug; 98(2):90-3. PubMed ID: 9724005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity.
    van Walderveen MA; Truyen L; van Oosten BW; Castelijns JA; Lycklama à Nijeholt GJ; van Waesberghe JH; Polman C; Barkhof F
    Arch Neurol; 1999 Mar; 56(3):345-51. PubMed ID: 10190826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
    Filippi M; Rovaris M; Capra R; Gasperini C; Yousry TA; Sormani MP; Prandini F; Horsfield MA; Martinelli V; Bastianello S; Kühne I; Pozzilli C; Comi G
    Brain; 1998 Oct; 121 ( Pt 10)():2011-20. PubMed ID: 9798753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadoteridol in multiple sclerosis patients. A comparison of single and triple dose with immediate vs. delayed imaging.
    Wolansky LJ; Finden SG; Chang R; Conigliari M; Lee HJ; Shaderowsky PD; Cook SD
    Clin Imaging; 1998; 22(6):385-92. PubMed ID: 9876905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.